Table 3.
The genes that overlapped among the top pathways significantly associated with clinical outcome (49 probe sets/22 genes).
| Gene ID | Gene description |
|---|---|
| HLA-DMA | Major histocompatibility complex, class II, DM alpha |
| HLA-DOA | Major histocompatibility complex, class II, DO alpha |
| CD79B | CD79b molecule, immunoglobulin-associated beta |
| IGH | Immunoglobulin heavy locus |
| IGKC | Immunoglobulin kappa constant |
| IGLC1 | Immunoglobulin lambda constant 1 (Mcg marker) |
| HLA-DQA1 | Major histocompatibility complex, class II, DQ alpha 1 |
| IGHM | Immunoglobulin heavy constant mu |
| CD79A | CD79a molecule, immunoglobulin-associated alpha |
| IGHD | Immunoglobulin heavy constant delta |
| CD3G | CD3g molecule, gamma (CD3-TCR complex) |
| CD3D | CD3d molecule, delta (CD3-TCR complex) |
| HLA-DPA1 | Major histocompatibility complex, class II, DP alpha 1 |
| GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
| LAT | Linker for activation of T cells |
| VAV1 | vav 1 guanine nucleotide exchange factor |
| INPP5D | Inositol polyphosphate-5-phosphatase, 145 kDa |
| IL2RB | Interleukin 2 receptor, β |
| IGHG1 | Immunoglobulin heavy constant gamma 1 (G1m marker) |
| CIITA | Class II, major histocompatibility complex, transactivator |
| IL21R | Interleukin 21 receptor |
| STAT1 | Signal transducer and activator of transcription 1, 91 kDa |